TerminatedNot Applicable

Evaluation of MoodRing on Improving the Quality of Depression Management in Adolescents

Stopped: The study was terminated prior to being able to recruit the full sample due to lack of funding and expiration of time on the award. The sample recruited completed the entire 6 month study.

United States73 participantsStarted 2022-05-12

Plain-language summary

The MoodRing intervention is a mobile application for adolescents, parents, and an accompanying web-based clinician portal which enables adolescents to monitor their mood through the use of passively collected smartphone data. This randomized controlled trial will evaluate whether MoodRing as compared to usual care improves the quality of depression management.

Who can participate

Age range

12 Years – 18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Adolescent: * age 12 -18 * prior or present history of depression per self-report and/or clinician diagnosis * scores between 5 or higher on PHQ-9 consistent with at least mild symptoms of depression * read and understand English * has an Android or iOS smartphone compatible with AWARE mobile application and access to a smartphone data plan * currently in United States Parent/Guardian: * adolescent qualifies for study and assents to enroll * understands English * currently in United States * has a smartphone device that can download the intervention application Healthcare Provider: \- involved in providing mental health treatment (psychotherapy or antidepressant prescribing or making referrals) to adolescent participant - can be a primary care provider, therapist, subspecialist, psychiatrist Exclusion Criteria: Adolescent: * currently actively suicidal (have suicidal thoughts and plan with an intent to act on it) * plans to travel to countries belonging to the European Union (Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, The Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden), the United Kingdom (England, Scotland, Wales, and Northern Ireland), Norway, Iceland, or Lichtenstein in the next 6 months for more than 2 weeks at a time Parent: \- If their adolescent child is excluded Healthcare Provid…

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change From Baseline in Self-management at 3 Months

Timeframe: From baseline to 3 months

Trial details

NCT IDNCT05376358

SponsorAna Radovic

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-03-27

Results submitted2025-03-20

View on ClinicalTrials.gov More Depression in Adolescence trials